Amgen Inc. - Common Stock (AMGN) — AI analysis & news
Amgen Inc. - Common Stock (AMGN) stock: 12 recent news items, positive aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 12 indexed AMGN stories, aggregate finance-aware sentiment is positive (+0.36 on a -1 to +1 scale).
Latest AMGN news
- Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026? - The Motley Fool · The Motley Fool
- Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? - Yahoo Finance · Yahoo Finance
- Amgen drug combined with immunotherapy extends survival in lung cancer trial - Reuters · Reuters
- Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer · CNBC
- Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer - CNBC · CNBC
- ESMO: Amgen’s Imdelltra drives massive survival benefit in ‘watershed moment’ for small cell lung cancer - Fierce Pharma · Fierce Pharma
- Oppenheimer raises Amgen stock price target on growth drivers By Investing.com - Investing.com Nigeria · Investing.com Nigeria
- Oppenheimer raises Amgen stock price target on growth drivers By Investing.com - Investing.com UK · Investing.com UK
- Amgen (AMGN) Gains As Market Dips: What You Should Know - Yahoo Finance · Yahoo Finance
- Amgen stock hits all-time high at 447.09 USD By Investing.com - Investing.com Nigeria · Investing.com Nigeria
- Amgen Inc. (AMGN) Stock Forecasts - Yahoo Finance · Yahoo Finance
- Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool · The Motley Fool
FAQ
What is the current sentiment for AMGN stock?
Aggregate finance-aware sentiment across the last 12 indexed AMGN news stories is positive (+0.36 on a -1 to +1 scale).